Header cover image

U.K. (FTSE) Healthcare Sector Analysis

UpdatedDec 05, 2022
DataAggregated Company Financials
Companies119
  • 7D2.0%
  • 3M4.7%
  • 1Y4.2%
  • YTD0.9%

Over the last 7 days, the Healthcare industry has risen 2.0%, driven by gains from AstraZeneca of 2.0%. This means that the industry has gained 4.2% over the past year. As for the next few years, earnings are expected to grow by 23% per annum.

Sector Valuation and Performance

Has the U.K. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 05 Dec 2022UK£280.6bUK£94.6bUK£6.6b36.9x42.6x3x
Wed, 02 Nov 2022UK£266.0bUK£95.5bUK£4.0b30.2x66.4x2.8x
Fri, 30 Sep 2022UK£252.8bUK£97.4bUK£4.0b27.9x63.4x2.6x
Sun, 28 Aug 2022UK£281.3bUK£93.9bUK£4.1b35.4x68.7x3x
Tue, 26 Jul 2022UK£288.9bUK£89.9bUK£4.9b33.2x58.7x3.2x
Thu, 23 Jun 2022UK£294.6bUK£88.9bUK£5.0b34.8x59.3x3.3x
Sat, 21 May 2022UK£302.3bUK£88.2bUK£5.0b28.1x60.6x3.4x
Mon, 18 Apr 2022UK£308.8bUK£81.2bUK£5.1b35.8x60.4x3.8x
Wed, 16 Mar 2022UK£279.6bUK£81.2bUK£5.1b31.2x55.2x3.4x
Fri, 11 Feb 2022UK£276.3bUK£75.9bUK£6.1b32.9x45.4x3.6x
Sun, 09 Jan 2022UK£277.2bUK£75.3bUK£6.0b31.9x46x3.7x
Tue, 07 Dec 2021UK£274.2bUK£76.0bUK£6.1b30.4x45x3.6x
Thu, 04 Nov 2021UK£294.3bUK£72.5bUK£7.7b30.1x38x4.1x
Sat, 02 Oct 2021UK£270.7bUK£72.3bUK£7.9b32.8x34.4x3.7x
Mon, 30 Aug 2021UK£274.5bUK£71.4bUK£7.9b33.7x35x3.8x
Tue, 06 Jul 2021UK£251.2bUK£71.2bUK£7.8b37.9x32.2x3.5x
Fri, 09 Apr 2021UK£217.4bUK£68.8bUK£8.7b33x25x3.2x
Thu, 31 Dec 2020UK£219.9bUK£69.8bUK£8.1b43.6x27.1x3.2x
Sun, 04 Oct 2020UK£235.8bUK£70.4bUK£8.3b41.2x28.6x3.3x
Wed, 08 Jul 2020UK£241.2bUK£72.2bUK£8.6b36.4x28.2x3.3x
Tue, 31 Mar 2020UK£213.3bUK£72.1bUK£7.1b33.1x30.1x3x
Fri, 03 Jan 2020UK£239.2bUK£68.4bUK£6.6b35.3x36.1x3.5x
Price to Earnings Ratio

36.1x


Total Market Cap: UK£239.2bTotal Earnings: UK£6.6bTotal Revenue: UK£68.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthcare Sector Price to Earnings3Y Average 42x20212022
Current Industry PE
  • Investors are relatively neutral on the British Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 42.0x.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare sector?

GB Market0.80%
Healthcare1.99%
Life Sciences4.24%
Pharma2.20%
Biotech1.87%
Healthtech1.43%
Healthcare Services0.89%
Medical Equipment-0.86%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 50.3x.
    • Analysts are expecting annual earnings growth of 21.8%, which is higher than its past year's earnings decline of 43.4% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 24% over the next 5 years.
  • This is better than its past earnings decline of 34% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£111.782.0%
+UK£3.5b
36.5%PE104x
GSK GSKUK£14.242.3%
+UK£1.1b
-25.8%PE12.9x
HCM HUTCHMED (China)UK£2.2725.8%
+UK£393.0m
-55.4%PS5.8x
ONT Oxford Nanopore TechnologiesUK£2.756.4%
+UK£136.5m
-59.0%PS11.5x
ABC AbcamUK£13.693.7%
+UK£115.0m
-18.1%PE429.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ERGO

UK£13.80

Ergomed

7D

6.0%

1Y

7.4%

GSK

UK£14.24

GSK

7D

2.3%

1Y

-25.8%

MXCT

UK£4.92

MaxCyte

7D

-4.5%

1Y

-30.7%

AZN

UK£111.78

AstraZeneca

7D

2.0%

1Y

36.5%

PRTC

UK£2.94

PureTech Health

7D

8.3%

1Y

5.2%

AGY

UK£0.13

Allergy Therapeutics

7D

-11.7%

1Y

-62.7%

MDC

UK£4.95

Mediclinic International

7D

-0.3%

1Y

69.8%

ONT

UK£2.75

Oxford Nanopore Technologies

7D

6.4%

1Y

-59.0%

HCM

UK£2.27

HUTCHMED (China)

7D

25.8%

1Y

-55.4%

ABC

UK£13.69

Abcam

7D

3.7%

1Y

-18.1%

IHC

UK£0.66

Inspiration Healthcare Group

7D

-22.8%

1Y

-40.2%